GHSI - Guardion Health Sciences, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
San Diego,
United States
Type: Equity
GHSI price evolution
GHSI
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.82 | $5.61 | $6.36 | $7.66 |
| Short term investments | ||||
| Net receivables | $0.01 | $2.1 | $2.27 | $1.77 |
| Inventory | $0.08 | $2.13 | $2.68 | $2.45 |
| Total current assets | $15.29 | $10.38 | $11.88 | $12.84 |
| Long term investments | ||||
| Property, plant & equipment | $0.01 | $0.03 | $0.03 | $0.04 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.01 | $0.03 | $0.03 | $0.04 |
| Total investments | ||||
| Total assets | $15.3 | $10.41 | $11.92 | $12.88 |
| Current liabilities | ||||
| Accounts payable | $0.11 | $0.41 | $0.61 | $0.88 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $0.92 | $1.27 | $1.32 | $1.43 |
| Long term debt | ||||
| Total noncurrent liabilities | $0.63 | $5.72 | $2.45 | $3.74 |
| Total debt | ||||
| Total liabilities | $1.55 | $6.99 | $3.77 | $5.18 |
| Shareholders' equity | ||||
| Retained earnings | -$87.99 | -$98.31 | -$93.57 | -$93.99 |
| Other shareholder equity | ||||
| Total shareholder equity | $13.75 | $3.41 | $8.15 | $7.7 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.36 | $15.91 | $4.09 | $8.53 |
| Short term investments | $5 | |||
| Net receivables | $2.27 | $1.92 | $1.41 | $0.01 |
| Inventory | $2.68 | $3.12 | $0.37 | $0.38 |
| Total current assets | $11.88 | $21.64 | $12.07 | $9.09 |
| Long term investments | ||||
| Property, plant & equipment | $0.03 | $0.05 | $0.14 | $0.7 |
| Goodwill & intangible assets | $11.26 | $0.05 | ||
| Total noncurrent assets | $0.03 | $0.05 | $11.39 | $0.77 |
| Total investments | $5 | |||
| Total assets | $11.92 | $21.69 | $23.46 | $9.86 |
| Current liabilities | ||||
| Accounts payable | $0.61 | $1.52 | $0.24 | $0.61 |
| Deferred revenue | ||||
| Short long term debt | $0 | $0.02 | $0.16 | |
| Total current liabilities | $1.32 | $4.01 | $1.16 | $1.07 |
| Long term debt | $0 | $0.27 | ||
| Total noncurrent liabilities | $2.45 | $4.51 | $0 | $0.27 |
| Total debt | $0 | $0.03 | $0.43 | |
| Total liabilities | $3.77 | $8.52 | $1.16 | $1.35 |
| Shareholders' equity | ||||
| Retained earnings | -$93.57 | -$93.72 | -$78.8 | -$54.08 |
| Other shareholder equity | ||||
| Total shareholder equity | $8.15 | $7.92 | $22.3 | $8.52 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.07 | $3 | $2.94 | $3.34 |
| Cost of revenue | $0.04 | $1.82 | $1.59 | $1.88 |
| Gross Profit | $0.04 | $1.18 | $1.35 | $1.46 |
| Operating activities | ||||
| Research & development | $0 | $0 | $0.01 | |
| Selling, general & administrative | $1.4 | $2.2 | $2.04 | $2.22 |
| Total operating expenses | $1.42 | $2.73 | $2.44 | $2.23 |
| Operating income | -$1.38 | -$1.55 | -$1.09 | -$0.77 |
| Income from continuing operations | ||||
| EBIT | $10.32 | -$4.75 | $0.42 | $0.37 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $10.32 | -$4.75 | $0.42 | $0.37 |
| Income (for common shares) | $10.32 | -$4.75 | $0.42 | $0.37 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12.25 | $11.05 | $7.23 | $1.89 |
| Cost of revenue | $6.85 | $6.53 | $4.12 | $1.95 |
| Gross Profit | $5.39 | $4.52 | $3.11 | -$0.06 |
| Operating activities | ||||
| Research & development | $0.15 | $0.19 | $0.06 | $0.16 |
| Selling, general & administrative | $9.19 | $11.65 | $13.53 | $8.9 |
| Total operating expenses | $9.73 | $21.94 | $27.86 | $8.49 |
| Operating income | -$4.34 | -$17.42 | -$24.75 | -$8.55 |
| Income from continuing operations | ||||
| EBIT | $0.16 | -$14.92 | -$24.75 | -$8.56 |
| Income tax expense | ||||
| Interest expense | $0.01 | |||
| Net income | ||||
| Net income | $0.16 | -$14.92 | -$24.75 | -$8.57 |
| Income (for common shares) | $0.16 | -$15.86 | -$24.75 | -$8.57 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $10.32 | -$4.75 | $0.42 | $0.37 |
| Operating activities | ||||
| Depreciation | $0 | $0 | $0 | $0 |
| Business acquisitions & disposals | $16.25 | $0.02 | ||
| Stock-based compensation | $0.01 | $0.01 | $0 | $0.03 |
| Total cash flows from operations | -$1.08 | -$0.75 | -$1.32 | -$0.77 |
| Investing activities | ||||
| Capital expenditures | -$0 | |||
| Investments | ||||
| Total cash flows from investing | $16.25 | $0.02 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.06 | |||
| Net borrowings | ||||
| Total cash flows from financing | -$5.95 | $0.06 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $9.22 | -$0.75 | -$1.3 | -$0.71 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $0.16 | -$14.92 | -$24.75 | -$8.57 |
| Operating activities | ||||
| Depreciation | $0.02 | $1.25 | $0.91 | $0.22 |
| Business acquisitions & disposals | $0.02 | -$25.94 | ||
| Stock-based compensation | -$0 | $0.23 | $0.6 | -$0.4 |
| Total cash flows from operations | -$4.37 | -$7.45 | -$10.64 | -$8.01 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.01 | -$0.07 | -$0.03 |
| Investments | $5 | -$5 | ||
| Total cash flows from investing | $0.02 | $4.99 | -$31.01 | -$0.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.06 | $9.96 | $37.23 | $5.45 |
| Net borrowings | ||||
| Total cash flows from financing | -$5.19 | $14.27 | $37.23 | $5.45 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$9.55 | $11.81 | -$4.42 | -$2.6 |
News
|
Guardion Health Sciences Announces Delisting and New Interim CEO
TipRanks · via Yahoo Finance
7 Oct 2024
|
|
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Simply Wall St. via Yahoo Finance
1 Apr 2024
|
|
Guardion Health Sciences Insider Ups Holding By 115% During Year
Simply Wall St. via Yahoo Finance
28 Jun 2023
|
|
Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Shares Leap 29% Yet They're Still Not Telling The...
Simply Wall St. via Yahoo Finance
19 Apr 2023
|
|
51 Biggest Movers From Yesterday
Benzinga
7 Apr 2022
|
|
Trading Penny Stocks on April 6th, MOBQ Stock Pushes Up
St. Joseph News-Press
6 Apr 2022
|
|
21 Stocks Moving in Wednesday's Pre-Market Session
Benzinga
6 Apr 2022
|
|
4 Top Penny Stocks To Buy For Under $1 This Week
Entrpreneur
9 Mar 2022
|
|
42 Stocks Moving in Monday's Pre-Market Session
Benzinga
7 Mar 2022
|
|
28 Stocks Moving in Wednesday's Pre-Market Session
Benzinga
2 Mar 2022
|
Fundamentals
| Market cap | $4.13M |
|---|---|
| Enterprise value | -$10.69M |
| Shares outstanding | 1.28M |
| Revenue | $9.35M |
|---|---|
| EBITDA | $6.39M |
| EBIT | $6.37M |
| Net Income | $6.37M |
| Revenue Q/Q | -97.39% |
| Revenue Y/Y | -17.77% |
| P/E ratio | 0.65 |
|---|---|
| EV/Sales | -1.14 |
| EV/EBITDA | -1.67 |
| EV/EBIT | -1.68 |
| P/S ratio | 0.44 |
| P/B ratio | 0.30 |
| Book/Share | 10.71 |
| Cash/Share | 11.54 |
| EPS | $4.96 |
|---|---|
| ROA | 50.49% |
| ROE | 77.24% |
| Debt/Equity | 0.46 |
|---|---|
| Net debt/EBITDA | -2.08 |
| Current ratio | 16.67 |
| Quick ratio | 16.59 |